Chest-CAD

by Imagen Technologies  · Based in United States →AI-Enabled Imaging Solutions For Superior Quality and Outcomes
Emergency Medicine Pulmonology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Chest-CAD by Imagen Technologies is an FDA-cleared computer-assisted detection (CADe) software device designed to assist physicians in identifying and categorizing suspicious regions of interest (ROIs) on adult chest X-rays. The underlying AI model was trained on a massive proprietary dataset, encompassing all abnormalities screenable on a chest X-ray. In clinical studies, Chest-CAD was shown to reduce diagnostic errors by 40% for clinicians. It detects and highlights suspicious regions, assigning them to categories such as Cardiac, Mediastinum/Hila, Lungs, Pleura, Bones, Soft Tissues, Hardware, or Other. The device integrates seamlessly into existing PACS workflows, allowing physicians to toggle the AI overlay on or off for concurrent review. Imagen Technologies aims to democratize access to world-class imaging by providing AI-enabled diagnostic services that improve diagnostic accuracy, enhance the patient experience, reduce costs, and alleviate clinician burnout.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection and categorization of ROIs on chest X-rays
  • Identifies suspicious regions in categories: Cardiac, Mediastinum/Hila, Lungs, Pleura, Bones, Soft Tissues, Hardware, Other
  • Reduces diagnostic errors by 40% in clinical studies
  • Concurrent reading aid for physicians
  • Integrates with Picture Archiving and Communication System (PACS) viewers
  • Cloud-based processing and delivery
  • Deep learning algorithms for computer vision
  • Provides bounding boxes and labels for detected ROIs

Use Cases

  • Assisting physicians in interpreting adult chest radiographs
  • Reducing misinterpretation rates in diagnostic imaging
  • Facilitating earlier disease detection and intervention
  • Improving diagnostic accuracy and consistency
  • Enhancing clinician efficiency and reducing burnout
  • Minimizing unnecessary ER and specialist visits

What Physicians Need to Know

Evidence Base
Chest-CAD is an FDA-cleared deep learning algorithm, trained on a massive proprietary dataset encompassing all abnormalities screenable on a chest X-ray. It identifies suspicious regions of interest (ROIs) and assigns them to eight clinical categories consistent with Radiological Society of North America (RSNA) reporting guidelines.
Clinical Validation Studies
The device received FDA 510(k) clearance in 2021. A retrospective multiple reader, multiple case (MRMC) study demonstrated that the accuracy of readers aided by Chest-CAD was superior to unaided readers, with reader AUC estimates improving from 0.836 to 0.894. Reader sensitivity improved from 0.757 to 0.856, and specificity from 0.843 to 0.870. Another clinical study showed Chest-CAD reduced errors by 40%. A study published in Scientific Reports indicated the AI model performed on par with radiologists and closed the accuracy gap between radiologists and non-radiologist physicians. Standalone performance on 20,000 adult chest X-ray cases showed an overall AUC of 97.6%, sensitivity of 90.8%, and specificity of 88.7%. When aided by AI, radiologists' accuracy rose from an AUC of 86.5% to 90%, and internal medicine physicians improved from 80% to 89.5%.
Alert Fatigue Management
The Chest-CAD overlay can be toggled on or off by the physician within their Picture Archiving and Communication System (PACS) viewer, allowing for concurrent review and user control. If no suspicious ROI is detected, the overlay explicitly states 'No ROI(s) Detected'.
Override Rate Data
Specific override rate data for Chest-CAD is not publicly available in the provided information.
Differential Diagnosis Support
Chest-CAD assists physicians by identifying suspicious regions of interest (ROIs) and categorizing them into one of eight clinical categories: Cardiac, Mediastinum/Hila, Lungs, Pleura, Bones, Soft Tissues, Hardware, or Other. This categorization helps guide further interpretation and narrows down potential areas of concern.
Guideline Update Frequency
Information regarding the specific frequency of guideline updates for Chest-CAD's underlying algorithms or how it incorporates new clinical guidelines is not publicly available in the provided context.
Clinical Workflow Integration
Chest-CAD is designed as a concurrent reading aid for physicians and integrates seamlessly into existing X-ray reading workflows and PACS systems, without requiring new PACS technology or costly re-training. It generates its output as a DICOM Presentation State file. The device is part of Imagen's 'Diagnostics as a Service (DaaS) platform,' which includes comprehensive support for EMR integration and IT services.
Decision Audit Trail
Details specifically on a decision audit trail for physician interactions with Chest-CAD (e.g., acceptance or rejection of AI findings) are not publicly available in the provided information.
Physician Tip

Leverage Chest-CAD as a concurrent reading aid to significantly enhance your accuracy in detecting suspicious regions on chest X-rays, especially if you are a non-radiologist. Utilize the categorized ROIs (Cardiac, Mediastinum/Hila, Lungs, Pleura, Bones, Soft Tissues, Hardware, or Other) to efficiently guide your further investigation and refine differential diagnoses. Take advantage of the toggle function within your PACS viewer to manage the AI overlay, ensuring it complements your workflow without causing distraction. Always remember that Chest-CAD is an assistive tool intended to augment, not replace, your clinical judgment and diagnostic role.

Chest-CAD is engineered for seamless integration into existing X-ray reading workflows and Picture Archiving and Communication Systems (PACS), eliminating the need for new PACS technology or extensive re-training. Its output is delivered as a DICOM Presentation State file, ensuring broad compatibility with standard imaging infrastructure. As part of Imagen's 'Diagnostics as a Service (DaaS) platform,' it offers comprehensive integration support, including EMR integration and IT services, to streamline its adoption into your practice.

Details

Category Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Contact for pricing Solution-based; Contact Imagen Technologies for specific pricing models and tiers.
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Chest-CAD received FDA 510(k) clearance (K210666) on July 20, 2021, as a Class II medical image analyzer (Product Code MYN) for computer-assisted detection (CADe) of suspicious regions in adult chest X-rays.

Integrations
EHR Not specified
Specialties Emergency Medicine, Pulmonology, Radiology

What the Web Says

Chest-CAD, developed by Imagen Technologies, is an FDA-approved deep-learning AI software designed to assist physicians in interpreting adult chest X-rays by identifying and categorizing suspicious regions of interest. Studies indicate that Chest-CAD can significantly improve the accuracy of chest X-ray interpretation, particularly for non-radiologist physicians, making their diagnostic performance comparable to that of radiologists when aided by the system. The software has demonstrated high overall accuracy, sensitivity, and specificity in detecting various chest abnormalities, including lung nodules, consolidation, and pneumothorax.

Overall: Positive

Strengths

  • Improves overall physician accuracy in chest X-ray interpretation, especially for non-radiologists.
  • Helps bridge the accuracy gap between radiologists and non-radiologist physicians.
  • High overall AUC, sensitivity, and specificity in identifying chest abnormalities.
  • Detects, categorizes, and localizes suspicious regions across eight clinical categories.
  • Can reduce errors in chest X-ray interpretation.
  • Potentially valuable in settings with limited access to radiologists, such as rural areas or low-resource environments.

Limitations

  • Some older CAD systems showed low specificity and high false-positive rates when used as a primary reader.
  • The effectiveness of CAD can vary based on the experience level of the reader, with less significant benefits for highly experienced radiologists.
  • One study suggested that CAD did not improve the performance of chest or general radiologists in terms of follow-up rates for actionable nodules, and non-radiologists were more vulnerable to false-positive marks.
  • One AI-based CAD system was found to be inferior to radiologists as a primary reader for lung nodule detection in chest phantoms.

Based on reviews from: AuntMinnie, EMJ, accessdata.fda.gov, Imagen Technologies, PMC, AJR Online

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Chest-CAD

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AuntMinnie
AI lifts nonradiologists' x-ray interpretation skill levels
A study published in Scientific Reports found that Imagen Technologies' Chest-CAD AI model performed on par with radiologists in detecting abnormalities on chest x-rays, effectively closing the accuracy gap for non-radiologist physicians. The deep-learning algorithm, FDA-approved in 2021, identifies suspicious regions of interest and categorizes them according to RSNA guidelines.
2024-10
Imagen Newsroom
Deep learning improves physician accuracy in the comprehensive detection of abnormalities on chest X-rays
Imagen's AI software, Chest-CAD, trained with deep learning, significantly improved the accuracy and speed of physicians, especially non-radiologists, in interpreting chest X-rays, making them as accurate as radiologists. The software detects, categorizes, and localizes suspicious regions on chest X-rays, and a clinical study showed it reduced errors by 40%.
2024-10
Respiratory Medicine Case Reports (via Imagen Newsroom)
Reevaluation of missed lung cancer with artificial intelligence
Imagen's FDA-cleared AI software, Chest-CAD, successfully highlighted a previously missed, life-threatening finding in a chest X-ray during unaided interpretation, demonstrating its ability to detect suspicious regions of interest.
2022-03
PRNewswire (via Imagen Newsroom)
Imagen Technologies Announces FDA Clearance of Aorta-CAD
Imagen Technologies announced the U.S. Food and Drug Administration's 510(k) clearance of Aorta-CAD, a new computer-assisted detection (CADe) device that expands its Diagnostics as a Service platform capabilities.
2022-12
FDA
Chest-CAD FDA 510(k) Clearance Letter
The FDA granted 510(k) clearance to Imagen Technologies' Chest-CAD on July 20, 2021. Chest-CAD is a computer-assisted detection (CADe) software device that uses machine learning to analyze adult chest radiographs, identifying, categorizing, and highlighting suspicious regions of interest as a concurrent reading aid for physicians.
2021-07
Regulations.gov
Action Requested to Address AI Innovation Gap in Healthcare
A petition highlights that Imagen's Chest-CAD (K210666) received FDA clearance for multiple regions of interest, though the output is non-specific, as part of a broader discussion on addressing the innovation gap in healthcare through AI-powered tools.
2025-10
MDPI
LungVisionNet: A Hybrid Deep Learning Model for Chest X-Ray Classificationu2014A Case Study at King Hussein Cancer Center (KHCC)
A research paper references Imagen's FDA-approved AI system Chest-CAD, noting its use of deep learning to assist in identifying anomalies in chest X-rays and its achievement of 97.6% AUC in enhancing physician accuracy when trained on a substantial dataset.
2025-11
AIMS Press
The evolving landscape: Role of artificial intelligence in cancer detection
This article mentions Imagen Technologies' Chest-CAD, stating that it helps identify spots on chest X-rays using AI, addressing a previous misinterpretation rate of 47% by clinicians.
2024-05

Videos

Product demos, reviews, and walkthroughs for Chest-CAD.

View all on YouTube

Frequently Asked Questions

Chest-CAD systems are designed to integrate into existing radiology workflows, often by analyzing chest radiographs and providing preliminary reports or highlighting suspicious regions of interest. They can assist referring clinicians with immediate insights for patient care and help radiologists prioritize worklists, shorten reporting times, and potentially enhance diagnostic performance as a second opinion.
Chest-CAD systems are trained to detect various abnormalities on chest X-rays, including lung nodules, consolidations, pneumothorax, pleural effusion, and other findings across regions like the lungs, pleura, mediastinum/hila, and heart. Some systems can also identify interstitial thickening.
Several Chest-CAD solutions have received regulatory clearances, such as Class II clearance from the U.S. Food and Drug Administration (FDA) and Medical Device Class IIa in Europe (CE mark). These clearances indicate that the software meets specific safety and effectiveness standards for its intended use as a computer-assisted detection tool.
Chest-CAD systems are typically designed to be HIPAA compliant, ensuring the secure handling and processing of patient data. Proper data anonymization techniques are crucial when preparing medical data for use in AI training and deployment to protect patient identity.
Limitations of Chest-CAD include the potential for false-positive results, which could lead to unnecessary further examinations, and false-negatives, where abnormalities are overlooked. While AI can enhance diagnostic accuracy, it is intended as an aid and not a replacement for the physician's interpretation or other diagnostic testing.
Yes, there are several other AI-powered computer-aided detection (CAD) solutions for chest X-ray analysis from various manufacturers. These alternatives often focus on detecting similar abnormalities like lung nodules, pneumonia, and pneumothorax, with some offering features like triage and notification for critical findings. Comparisons often involve diagnostic accuracy (sensitivity, specificity, AUC) and specific features.
Specific pricing for medical Chest-CAD software is not readily available in public search results, but general AI software and CAD services often follow subscription models or per-use fees. Factors influencing cost can include the complexity of the AI model, the scope of detectable abnormalities, integration requirements with existing PACS/EMR systems, and the volume of studies processed.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

More from Imagen Technologies

Aorta-CAD
Imagen Technologies
Cardiology AI
Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows.
FractureDetect (FX)
Imagen Technologies
Radiology & Imaging AI
FractureDetect (FX) by Imagen Technologies is an FDA-cleared AI-powered computer-assisted detection and diagnosis (CAD) software device designed to assist clinicians in detecting hard-to-spot fractures on musculoskeletal radiographs in adults, thereby improving diagnostic accuracy and reducing missed fractures.
Imagen OsteoDetect
Imagen Technologies
Clinical Decision Support & Reference
Imagen OsteoDetect is an FDA-cleared AI-driven software that assists clinicians in detecting distal radius fractures on adult wrist X-rays, enhancing diagnostic accuracy and speed.
Lung-CAD
Imagen Technologies
Oncology AI
Imagen Technologies provides FDA-cleared, AI-enabled diagnostic imaging software, including Lung-CAD, to enhance diagnostic quality, efficiency, and patient care in radiology and primary care settings.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.